Let us know if we're missing any workplace or industry recognition –
The earlier the diagnosis, the faster the cure. DiagnoCure Inc. is a developer of diagnostic tests for early-stage cancer identification. The company's lead products are molecular diagnostic tests and immunoassay tests focusing on the diagnosis of cancers. Its products can be used to screen, diagnose, and monitor cancer conditions and plan therapy treatments. Commercialized or development-stage products include tests for prostate, colorectal, and breast cancer. The company, which also provides laboratory services, was incorporated in 1994.